Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 12281 - 12300 out of 553697 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 5 mg tablet, 56 | Tablet 5 mg, 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 5 mg tablet, 56 | Tablet 5 mg, 56 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 5 mg tablet, 56 | Tablet 5 mg, 56 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 5 mg tablet, 56 | Tablet 5 mg, 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 5 mg tablet, 56 | Tablet 5 mg, 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 10 mg tablet, 56 | Tablet 10 mg, 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 15 mg tablet, 56 | Tablet 15 mg, 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 15 mg tablet, 56 | Tablet 15 mg, 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 20 mg tablet, 56 | Tablet 20 mg, 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 20 mg tablet, 56 | Tablet 20 mg, 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 5 mg tablet, 56 | Tablet 5 mg, 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 5 mg tablet, 56 | Tablet 5 mg, 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01FC01) daratumumab | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FY02) nivolumab and relatlimab | Opdualag injection, 20 mL vial | Solution concentrate for I.V. infusion containing 240 mg nivolumab and 80 mg relatlimab in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FY02) nivolumab and relatlimab | Opdualag injection, 20 mL vial | Solution concentrate for I.V. infusion containing 240 mg nivolumab and 80 mg relatlimab in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01XE27) ibrutinib | Imbruvica 140 mg capsule, 90 | Capsule 140 mg, 90 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagPtyLtd |
| Australia | (L01XE38) Cobimetinib | Cotellic 20 mg tablet, 63 | Tablet 20 mg, 63 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | RocheProductsPtyLtd |
| Australia | (L01XE42) ribociclib | Kisqali 200 mg tablet, 21 | Tablet 200 mg, 21 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01XE42) ribociclib | Kisqali 200 mg tablet, 63 | Tablet 200 mg, 63 pcs | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01XE27) ibrutinib | Imbruvica 140 mg capsule, 120 | Capsule 140 mg, 120 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagPtyLtd |
Pages
